Correlation Between Kiromic Biopharma and Zura Bio

Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kiromic Biopharma and Zura Bio Limited, you can compare the effects of market volatilities on Kiromic Biopharma and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Zura Bio.

Diversification Opportunities for Kiromic Biopharma and Zura Bio

-0.08

Correlation Coefficient

Kiromic Biopharma  Zura Bio

Good diversification

The 3 months correlation between Kiromic and Zura is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Zura Bio go up and down completely randomly.

Pair Corralation between Kiromic Biopharma and Zura Bio

Given the investment horizon of 90 days Kiromic Biopharma is expected to under-perform the Zura Bio. But the stock apears to be less risky and, when comparing its historical volatility, Kiromic Biopharma is 1.63 times less risky than Zura Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Zura Bio Limited is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  816.00  in Zura Bio Limited on August 31, 2024 and sell it today you would lose (516.00) from holding Zura Bio Limited or give up 63.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	35.9%
Values	Daily Returns

Kiromic Biopharma  vs.  Zura Bio Limited

Kiromic Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kiromic Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Kiromic Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Zura Bio Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Kiromic Biopharma and Zura Bio

The main advantage of trading using opposite Kiromic Biopharma and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.

The idea behind Kiromic Biopharma and Zura Bio Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.